A lack of framework for the validation of in silico models is a major barrier to those software industries engaged in healthcare. The Avicenna Alliance will work towards the creations of such a framework that would allow for maximum market uptake of medical software for pre-clinical and clinical use.
Data Protection and ensuring ease of access to health data for medical research purposes is a key priority of the Alliance.
Here’s something new! The Avicenna Alliance has joined Instagram to bring you the latest updates, insights, and highlights from the world of in silico medicine.
Did you enjoy AAD 2024 and want to rewatch presentations from world-class thought leaders? Or did you miss the event? This news is for you!
The BioTechX event in Basel provided an excellent opportunity for the Avicenna Alliance to engage with key pharmaceutical players and discuss the growing role of in silico methods in drug discovery and development, drug delivery and manufacturing.
Fill in the fields you find below
